COMP <GO>
MEDS vs COSM // OPERATING MARGIN
DataMeds AI Inc. (NASDAQ) VS. Cosmos Health Inc. (NASDAQ) • 15-METRIC TALLY: MEDS 1
— COSM 6
▲ OPERATING MARGIN LEADER: COSM
LAST: $2.03 (-7.73%) • MKT CAP: $9.8M
operating-margins
-60.00%
LAST: $0.28 (+11.45%) • MKT CAP: $27.9M
operating-margins
-25.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MEDS VS. COSM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MEDS | COSM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -27.50% | 12.10% | -39.60 | COSM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | -60.00% | -25.60% | -34.40 | COSM | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -29.30% | -30.70 | COSM | /net-margins <GO> |
| Revenue Growth (YoY) | 28.70% | 19.90% | +8.80 | MEDS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | COSM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.1 | 46.4 | -5.30 | COSM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.8M | $27.9M | -$18.1M | COSM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MEDS REV | COSM REV | MEDS GROSS % | COSM GROSS % | MEDS FCF | COSM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $23.3M | $65.3M | -27.5% | 12.1% | -$10.9M | -$8.5M |
| FY 2024 | $18.1M | $54.4M | 9.7% | 7.9% | -$1.2M | -$8.1M |
| FY 2023 | $0 | $53.4M | — | — | -$349.1K | -$15.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MEDS // BETA —
COSM // BETA —